Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Sex hormones affect brain injury differently in males and females.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Signaling pathways are crucial for hair growth in goats.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

BAF200 is essential for proper heart and coronary artery formation.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Researchers found new genes involved in hair growth, which could help develop new hair treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

XEDAR triggers a specific signaling pathway in cells.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Wnt5a slows down hair growth by blocking a specific pathway during hair regeneration.